ARCHIVES

FDA Approves Ixempra For Metastatic Breast Cancer Resistant To Other Therapy

This article is from The Cancer Letter archive.

Vol. 30 No. 10 | October 26, 2007

Download PDF Visit The Full Archive

Related Articles

Maria Carolina Hinestrosa, EVP of National Breast Cancer Coalition

June 26, 2009

NCI’s Rosenberg Confirms 2002 Immunotherapy Results

April 29, 2005

Three Cancer Centers Test Targeted Therapy For Resistant Acute Myelogenous Leukemia

July 26, 2002

Final Issue of 1981

December 11, 1981

Comprehensive Center NCAB Evaluations

June 2, 1978

Von Eschenbach Says He Will Step Down as NCI Director; No Acting Director Has Been Named.

March 24, 2006